Comparative evaluation of costs and healthcare resource utilization of oral selexipag versus inhaled treprostinil or oral treprostinil in patients with pulmonary arterial hypertension
Author:
Affiliation:
1. Putnam PHMR, Value Pricing and Access, New York, NY, USA;
2. Actelion Pharmaceuticals Ltd, Global Market Access, Allschwil, Switzerland
3. Janssen Scientific Affairs, LLC, Real World Value & Evidence, Titusville, NJ, USA
Publisher
Informa UK Limited
Subject
Health Policy
Link
https://www.tandfonline.com/doi/pdf/10.1080/13696998.2023.2204769
Reference34 articles.
1. 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension
2. Pathology of Pulmonary Hypertension
3. Pathogenesis of pulmonary arterial hypertension: lessons from cancer
4. Epidemiology of pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension: identification of the most accurate estimates from a systematic literature review
5. The Changing Picture of Patients With Pulmonary Arterial Hypertension in the United States
Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Oral Prostacyclin Pathway Agents Used in PAH: A Targeted Literature Review;ClinicoEconomics and Outcomes Research;2024-05
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3